Merck & Co and Lilly Asia Ventures will exit the biotherapeutics technology developer in an acquisition by Evotec that will be sized at up to $90m.
Drug discovery and development firm Evotec has agreed to acquire Just Biotherapeutics, a US-based protein therapeutics developer backed by pharmaceutical companies Eli Lilly and Merck & Co, for up to $90m.
Just Bio is developing technology intended to reduce the costs associated with designing, developing and manufacturing of biologics. Its research and development platform, J.Design, is a machine learning-based tool used to select molecules for further development.
The company also offers a platform that assists with the development of drug…
